In the News

1855 News Items found
Macropinocytosis
New research from the Craig Thompson Lab offers a closer look at the transcriptional activators, Yap/Taz, and the role they play in cell growth and macropinocytosis.
Carol Brown, MD
A team of experts at Memorial Sloan Kettering shared their insights on gynecologic cancer and women’s health in an Information Session for patients, caregivers and those at increased risk for the diseases.
Researchers Roisin O'Cearbhaill and Christopher Klebanoff
In the Clinic
MSK is a leader in developing new types of immunotherapy for gynecologic cancers, including tumors of the cervix, ovaries, and uterus.
Lisa M. DeAngelis
DeAngelis is acknowledged for her groundbreaking research in the field of neuro-oncology over her more than 30-year career.
Memorial Sloan Kettering exercise scientist Lee Jones
Q&A
People with prostate cancer can benefit from exercise in more ways than they might expect.
Memorial Sloan Kettering structural biologist Christopher Lima and physician-scientist Michael Glickman
In the Clinic
An antibody test developed at MSK could shed light on the immune response to the COVID-19 virus.
Regulatory proteins (gold balls) bind to enhancer regions (light blue) and promoter regions (pink) of DNA to form clusters that enable transcription (purple).
Scientists at the Sloan Kettering Institute are learning how far-flung regions of genes connect to start the process of making proteins.
Pathologist Matthew Hanna in front of a microscope
Collaboration leads to a new digital pathology tool that allows some doctors to diagnose patient tumors from home.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.
ESMO 2020
MSK physicians and scientists are involved in notable research to be presented during the virtual meeting.